Prognostic, Not Predictive: Reconsidering the “Immunotherapy-Resistant” Label in Infiltrative Hepatocellular Carcinoma
Clinical and Molecular Hepatology · 06.11.2026
DOI: 10.3350/cmh.2026.1165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 06.11.2026. Verfasst von Haitao Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital).
- Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital). luanxiaofeng2000@sina.com.
- Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital). 15382267266@163.com.
Zitieren
APA
Zhang, H., Wang, L., Luan, X., & Liu, H. (2026). Prognostic, Not Predictive: Reconsidering the “Immunotherapy-Resistant” Label in Infiltrative Hepatocellular Carcinoma. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.1165
Vancouver
Zhang H, Wang L, Luan X, Liu H. Prognostic, Not Predictive: Reconsidering the “Immunotherapy-Resistant” Label in Infiltrative Hepatocellular Carcinoma. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.1165
BibTeX
@article{Zhang2026,
author = {Zhang, Haitao and Wang, Lei and Luan, Xiaofeng and Liu, Hangyu},
title = {Prognostic, Not Predictive: Reconsidering the “Immunotherapy-Resistant” Label in Infiltrative Hepatocellular Carcinoma},
journal = {Clinical and Molecular Hepatology},
year = {2026},
doi = {10.3350/cmh.2026.1165}
}
EUVIMED